C

Can Fite Biopharma Ltd
TASE:CANF

Watchlist Manager
Can Fite Biopharma Ltd
TASE:CANF
Watchlist
Price: 1 ILS Market Closed
Market Cap: 78.6m ILS

Operating Margin
Can Fite Biopharma Ltd

-1 487.2%
Current
-1 222%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 487.2%
=
Operating Profit
-13m
/
Revenue
876k

Operating Margin Across Competitors

No Stocks Found

Can Fite Biopharma Ltd
Glance View

Market Cap
78.6m ILS
Industry
Biotechnology

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The firm co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

CANF Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 487.2%
=
Operating Profit
-13m
/
Revenue
876k
What is the Operating Margin of Can Fite Biopharma Ltd?

Based on Can Fite Biopharma Ltd's most recent financial statements, the company has Operating Margin of -1 487.2%.

Back to Top